Bean Extract-Based Gargle for Efficient Diagnosis of Active COVID-19 Infection Using Rapid Antigen Tests
The antigen-based rapid diagnostic test (Ag-RDT) using saliva specimens is fast, noninvasive, and suitable for SARS-CoV-2 self-testing, unlike nasopharyngeal swab (NPS) testing. We evaluated a novel Beanguard gargle (BG)-based virus collection method that can be applied to Ag-RDT as an alternative to the current RT-PCR with an NPS for early diagnosis of COVID-19. This clinical trial comprised 102 COVID-19-positive patients hospitalized after a governmental screening process and 100 healthy individuals. Paired NPS and BG-based saliva specimens from COVID-19 patients and healthy individuals were analyzed using NPS-RT-PCR, BG-RT-PCR, and BG-Ag-RDTs, whose diagnostic performance for detecting SARS-CoV-2 was compared. BG-Ag-RDTs showed high sensitivity (97.8%) and specificity (100%) in 45 patients within 6 days of illness and detected all cases of SARS-CoV-2 Alpha and Delta variants.
In 11 asymptomatic active COVID-19 cases, both BG-Ag-RDTs and BG-RT-PCR showed sensitivities and specificities of 100%. Sensitivities of BG-Ag-RDT and BG-RT-PCR toward salivary viral detection were highly concordant, with no discrimination between symptomatic (97.0%), asymptomatic (100%), or SARS-CoV-2 variant (100%) cases. The intermolecular interactions between SARS-CoV-2 spike proteins and truncated canavalin, an active ingredient from the bean extract (BE), were observed in terms of physicochemical properties. The detachment of the SARS-CoV-2 receptor-binding domain from hACE2 increased as the BE concentration increased, allowing the release of the virus from hACE2 for early diagnosis. Using BG-based saliva specimens remarkably enhances the Ag-RDT diagnostic performance as indicaid covid-19 rapid antigen test accuracyan alternative to NPS and enables noninvasive, rapid, and accurate COVID-19 self-testing and mass screening, supporting efficient COVID-19 management
An Ag-RDT is less likely to be accepted as an initial test method for early diagnosis owing to its low sensitivity.
- However, our self-collection method, Ag-RDT using BG-based saliva specimens, showed significantly enhanced detection sensitivity and specificity toward SARS-CoV-2 including the Alpha and Delta variants in all patients tested within 6 days of illness.
- The method represents an attractive alternative to nasopharyngeal swabs for the early diagnosis of symptomatic and asymptomatic COVID-19 cases.
- The evidence suggests that the method could have a potential for mass screening and monitoring of COVID-19 cases.
- The SARS-CoV-2 pandemic, which started in December 2019, has been posing significant challenges to the health care system worldwide.
- As the pandemic spreads with rapidly increasing number of positive cases, early diagnosis of infected patients is crucial to successfully limit the spread of the virus. Although the real-time reverse-transcription polymerase chain reaction (RT-qPCR) is the recommended laboratory method to diagnose COVID-19 infection, many factors such as availability of laboratory equipment, reagents and trained personnel affect the use of time-consuming molecular techniques.
- To facilitate on-the-spot diagnosis of COVID-19, SARS-CoV-2 rapid antigen tests were developed by several different manufacturers. The evaluation of such rapid tests is particularly important due to the recent unanimous agreement by the European Commission Member States on a recommendation setting out a framework for the use of antigen rapid tests that contains a list of the mutually recognized assays and the basis of independent validation protocols.
- To evaluate the on-field performance of ten commercially available SARS-CoV-2 antigen rapid tests (CLINITEST Rapid COVID-19 Antigen Test, GenBody COVID-19 Antigen Test, GENEDIA W COVID-19 Ag Test, Healgen Coronavirus Antigen Rapid Test, Humasis COVID-19 Ag Test, VivaDiag SARS-CoV-2 Ag Rapid Test, Helix i-SARS-CoV-2 Ag Rapid Test, Roche SARS-CoV-2 Rapid Antigen Test, Abbot COVID-19 Ag Rapid Test and Vazyme SARS-CoV-2 Antigen Detection Kit) and compare with RT-qPCR as a reference method, the Hungarian National Public Health Center provided 1,597 antigen rapid tests to the National Ambulance Service, COVID-testing trucks and two hospitals treating COVID-19 patients.
- Sensitivity, specificity and accuracy were determined by performing the rapid test directly from nasopharyngeal swab samples of symptomatic individuals. For strongly positive samples (Ct < 25) sensitivities ranged between 66.7% and 100%, while for positive samples (Ct < 30) they gave a maximum sensitivity of 87.5%. The specificity of the tests was ranging between 79% to 100%.
- The results presented here are of high importance to the European Commission and also help governmental decision-making regarding the application of the proper rapid tests for screening different at-risk populations. Nonetheless, SARS-Cov-2 rapid tests play an important role in early and on-the-spot diagnosis of potentially infected individuals.
Appropriate isolation guidelines for COVID-19 patients are warranted. Currently, isolating for fixed time is adapted in most countries.
However, given the variability in viral dynamics between patients, some patients may no longer be infectious by the end of isolation (thus they are redundantly isolated), whereas others may still be infectious. Utilizing viral test results to determine ending isolation would minimize both the risk of ending isolation of infectious patients and the burden due to redundant isolation of noninfectious patients. In our previous study, we proposed a computational framework using SARS-CoV-2 viral dynamics models to compute the risk and the burden of different isolation guidelines with PCR tests.
In this study, we extend the computational framework to design isolation guidelines for COVID-19 patients utilizing rapid antigen tests. Time interval of tests and number of consecutive negative tests to minimize the risk and the burden of isolation were explored. Furthermore, the approach was extended for asymptomatic cases. We found the guideline should be designed considering various factors: the infectiousness threshold values, the detection limit of antigen tests, symptom presence, and an acceptable level of releasing infectious patients. Especially, when detection limit is higher than the infectiousness threshold values, more consecutive negative results are needed to ascertain loss of infectiousness.
Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
GEN-B352-20tests | Accu test | 20 tests | 283.2 EUR |
Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
GEN-B352-40tests | Accu test | 40 tests | 385.2 EUR |
COVID-19 IgG/IgM Rapid Test Kit |
|||
UNCOV-20 | UnScience | 20T/kit | 186 EUR |
Panbio™ COVID-19 IgG/IgM Rapid Test |
|||
ICO-T402 | Abbott | 25 Tests/Kit | 264 EUR |
Panbio™ COVID-19 Ag Rapid Test Device |
|||
41FK10 | Abbott | 25 Tests/Kit | 115.2 EUR |
Panbio™ COVID-19 Ag Rapid Test Device (Nasal) |
|||
41FK11 | Abbott | 25 Tests/Kit | 128 EUR |
SARS-CoV-2 Antigen Rapid Test Kit |
|||
CoV2Ag-1 | UnScience | 1T | 9.6 EUR |
SARS-CoV-2 Antigen Rapid Test Kit |
|||
CoV2Ag-25 | UnScience | 25T/kit | 42 EUR |
NOVATest Antigen Rapid Test Kit (For Single Use) (NOVA Test) |
|||
nCov-500-01 | Atlas Link Technology | 1T | 162 EUR |
NOVATest Antigen Rapid Kit (NOVA Test) |
|||
nCov-500 | Atlas Link Technology | 20 Tests | 162 EUR |
SARS-CoV-2 Rapid Antigen Test Nasal |
|||
9901-NCOV-03G | Roche Diagnostics | 25 Tests/Kit | 112.8 EUR |
Human Streptococcus Pneumoniae (SP) Antigen Rapid Test Kit |
|||
abx092096-20tests | Abbexa | 20 tests | 477.6 EUR |
Avian Influenza Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092015-40tests | Abbexa | 40 tests | 518.4 EUR |
Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) |
|||
IOV87952 | INVBIO | 20T/kit | 46.8 EUR |
Newcastle Disease Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092016-40tests | Abbexa | 40 tests | 518.4 EUR |
Human Chlamydia Trachomatis Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092049-20tests | Abbexa | 20 tests | 276 EUR |
Avian Influenza H5 Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092014-40tests | Abbexa | 40 tests | 585.6 EUR |
Avian Influenza H7 Virus Antigen Rapid Test Kit (Colloidal gold) |
|||
abx092017-40tests | Abbexa | 40 tests | 518.4 EUR |
COVID-19 Nucleocapsid recombinant antigen |
|||
00221-V-100ugvial | Virogen | 100 ug/vial | 150 EUR |
TruStrip RDT Anthrax Protective antigen 83 (PA83) Rapid Test cards, 25/pk |
|||
800-100-RDT-25 | Alpha Diagnostics | 1 pk | 489.6 EUR |
2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) |
|||
GEN-402-25tests | All test | 25 tests | 292.8 EUR |
TruStrip RDT Zaire Ebola Virus antigen (GP) rapid test (visual results in 2-10 mins), 10 cassettes/pk |
|||
AE-320805-RDT-10 | Alpha Diagnostics | 1 pk | 343.2 EUR |
COVID-19 Nucleocapsid recombinant antigen C-terminal domain |
|||
00227-V-100ugvial | Virogen | 100 ug/vial | 150 EUR |
Melamine Rapid Test Kit |
|||
abx092011-50tests | Abbexa | 50 tests | 444 EUR |
Brucella Antibody Rapid Test Kit |
|||
abx092069-40tests | Abbexa | 40 tests | 427.2 EUR |
COVID-19 Spike-E-M Immunodominant regions recombinant antigen |
|||
00220-V-100ugvial | Virogen | 100 ug/vial | 150 EUR |
TruStrip RDT Canine distemper virus (hardpad disease) antigen rapid test card, results is 2-10 mins, 50 cards/pk |
|||
RV-501200-RDT | Alpha Diagnostics | 1 pk | Ask for price |
NOVATest IgG/IgM Antibody Rapid Test Kit (NOVA Test) |
|||
UNCOV-40 | Atlas Link Technology | 40 Tests | 115 EUR |
Melamine (MEL) Rapid Test Kit |
|||
abx092057-50tests | Abbexa | 50 tests | 444 EUR |
Quinolones (QNs) Rapid Test Kit |
|||
abx092065-40tests | Abbexa | 40 tests | 477.6 EUR |
Salbutamol (SAL) Rapid Test Kit |
|||
abx092060-50tests | Abbexa | 50 tests | 292.8 EUR |
Quinolones (QNs) Rapid Test Kit |
|||
abx092067-40tests | Abbexa | 40 tests | 477.6 EUR |
Clenbuterol (CLE) Rapid Test Kit |
|||
abx092058-50tests | Abbexa | 50 tests | 292.8 EUR |
Ractopamine (RAC) Rapid Test Kit |
|||
abx092059-50tests | Abbexa | 50 tests | 292.8 EUR |
Tetracycline (TCs) Rapid Test Kit |
|||
abx092063-50tests | Abbexa | 50 tests | 477.6 EUR |
Sulfonamides (Sas) Rapid Test Kit |
|||
abx092064-40tests | Abbexa | 40 tests | 477.6 EUR |
Cow Brucella Antibody Rapid Test Kit |
|||
abx092071-40tests | Abbexa | 40 tests | 427.2 EUR |
Goat Brucella Antibody Rapid Test Kit |
|||
abx092070-40tests | Abbexa | 40 tests | 427.2 EUR |
Ciprofloxacin (CPFX) Rapid Test Kit |
|||
abx092066-50tests | Abbexa | 50 tests | 477.6 EUR |
Pig Parvovirus Antibody Rapid Test Kit |
|||
abx092074-50tests | Abbexa | 50 tests | 385.2 EUR |
Procalcitonin rapid test (Colloidal Gold) |
|||
abx095264-80Units | Abbexa | 80 Units | 1144.8 EUR |
Chlamydia Rapid Test Device (Swab/Urine) |
|||
173-8537306 | Abbott | 20 Tests/Kit | 300 EUR |
Aflatoxin Rapid Test Kit (Colloidal gold) |
|||
abx092054-50tests | Abbexa | 50 tests | 477.6 EUR |
Dynamiker Monkeypox Virus Ag Rapid Test |
|||
DNK-2114-1 | Dynamiker Biotechnology | 20 tests | 702 EUR |
Salbutamol Rapid Test Kit (Colloidal gold) |
|||
abx092043-50tests | Abbexa | 50 tests | 410.4 EUR |
Quinolones Rapid Test Kit (Colloidal gold) |
|||
abx092046-50tests | Abbexa | 50 tests | 644.4 EUR |
Clenbuterol Rapid Test Kit (Colloidal gold) |
|||
abx092040-50tests | Abbexa | 50 tests | 326.4 EUR |
Ractopamine Rapid Test Kit (Colloidal gold) |
|||
abx092042-50tests | Abbexa | 50 tests | 360 EUR |
Zearalenone Rapid Test Kit (Colloidal gold) |
|||
abx092051-50tests | Abbexa | 50 tests | 493.2 EUR |
Zearalenone Rapid Test Kit (Colloidal gold) |
|||
abx092056-50tests | Abbexa | 50 tests | 510 EUR |
Sulfonamides Rapid Test Kit (Colloidal gold) |
|||
abx092047-50tests | Abbexa | 50 tests | 661.2 EUR |
Tetracycline Rapid Test Kit (Colloidal gold) |
|||
abx092048-50tests | Abbexa | 50 tests | 560.4 EUR |
Fetal Fibronectin rapid test (Colloidal Gold) |
|||
abx095261-80Units | Abbexa | 80 Units | 1863.6 EUR |
Deoxynivalenol Rapid Test Kit (Colloidal gold) |
|||
abx092052-50tests | Abbexa | 50 tests | 560.4 EUR |
Deoxynivalenol Rapid Test Kit (Colloidal gold) |
|||
abx092053-50tests | Abbexa | 50 tests | 560.4 EUR |
Chloramphenicol Rapid Test Kit (Colloidal gold) |
|||
abx092045-50tests | Abbexa | 50 tests | 427.2 EUR |
Human Echovirus (ECHO) IgM Rapid Test Kit |
|||
abx092093-20tests | Abbexa | 20 tests | 326.4 EUR |
Human Toxoplasma (TOX) IgG Rapid Test Kit |
|||
abx092098-20tests | Abbexa | 20 tests | 260.4 EUR |
GENLISA™ Human SARS-CoV-2 (Covid-19) Spike Protein Antigen Quantitative ELISA |
|||
KBVH015-10 | Krishgen | 12 × 8 wells | 1642.5 EUR |
Cattle and Goat Hydatid Antibody Rapid Test Kit |
|||
abx092072-40tests | Abbexa | 40 tests | 427.2 EUR |
Aflatoxin B1 Rapid Test Kit (Colloidal gold) |
|||
abx092055-50tests | Abbexa | 50 tests | 477.6 EUR |
Aflatoxin B1 Rapid Test Kit (Colloidal gold) |
|||
abx092050-50tests | Abbexa | 50 tests | 444 EUR |
TruStrip RDT Testosterone Rapid Test cards, 10/pk |
|||
1880-RDT-10 | Alpha Diagnostics | 1 pk | Ask for price |
Avian Influenza H5N1 Virus Antibody Rapid Test Kit |
|||
abx092075-40tests | Abbexa | 40 tests | 477.6 EUR |
Human Treponema Pallidum (TP) Antibody Rapid Test Kit |
|||
abx092101-20tests | Abbexa | 20 tests | 309.6 EUR |
Malachite Green Rapid Test Kit (Colloidal gold) |
|||
abx092041-10tests | Abbexa | 10 tests | 360 EUR |
Rabies Virus Antibodies Rapid Test Kit (Colloidal gold) |
|||
abx092033-40tests | Abbexa | 40 tests | 427.2 EUR |
Human Rubella Virus (RV) IgG Rapid Test Kit |
|||
abx092097-20tests | Abbexa | 20 tests | 260.4 EUR |
Human Rabies Virus (HRV) IgG Rapid Test Kit |
|||
abx092100-20tests | Abbexa | 20 tests | 410.4 EUR |
Human Hantavirus (HV) IgM / IgG Rapid Test Kit |
|||
abx092094-20tests | Abbexa | 20 tests | 326.4 EUR |
Human Hepatitis A Virus IgG Rapid Test Kit |
|||
abx092012-25tests | Abbexa | 25 tests | 510 EUR |
Influenza Rapid Test Control Pack (3 X 1.5mL) |
|||
KZMC033 | Zeptometrix | 3 X 1.5mL | 59 EUR |
Rotavirus Rapid Test Control Pack (2 X 1.5mL) |
|||
KZMC036 | Zeptometrix | 2 X 1.5mL | 59 EUR |
Human Enterovirus 71 (EV71) IgM Rapid Test Kit |
|||
abx092091-20tests | Abbexa | 20 tests | 410.4 EUR |
Adenovirus Rapid Test Control Pack (2 X 1.5mL) |
|||
KZMC035 | Zeptometrix | 2 X 1.5mL | 59 EUR |
Livingcare Group Covid-19 Day 2 Testing |
|||
COV3000 | Scientific Laboratory Supplies | PK200 | 2763.36 EUR |
Phenylethanolamine A Rapid Test Kit (Colloidal gold) |
|||
abx092044-50tests | Abbexa | 50 tests | 560.4 EUR |
Canine Parvovirus Antibodies Rapid Test Kit (Colloidal gold) |
|||
abx092032-40tests | Abbexa | 40 tests | 427.2 EUR |
Furaltadone Metabolite Rapid Test Kit (Colloidal gold) |
|||
abx092035-50tests | Abbexa | 50 tests | 644.4 EUR |
Pseudorabies Virus Antibodies Rapid Test Kit (Colloidal gold) |
|||
abx092026-50tests | Abbexa | 50 tests | 385.2 EUR |
Furazolidone Metabolite Rapid Test Kit (Colloidal gold) |
|||
abx092036-50tests | Abbexa | 50 tests | 644.4 EUR |
Nitrofurazone Metabolite Rapid Test Kit (Colloidal gold) |
|||
abx092038-50tests | Abbexa | 50 tests | 644.4 EUR |
Human Helicobacter Pylori (HP) IgG Rapid Test Kit |
|||
abx092090-20tests | Abbexa | 20 tests | 276 EUR |
GENLISA™ SARS-CoV-2 (Covid-19) Surrogate Virus Neutralization Test (sVNT) ELISA |
|||
KBVH400 | Krishgen | 12 × 8 wells | 3822 EUR |
Human Chlamydia Pneumoniae (CP) IgG Rapid Test Kit |
|||
abx092079-20tests | Abbexa | 20 tests | 309.6 EUR |
Human Chlamydia Pneumoniae (CP) IgM Rapid Test Kit |
|||
abx092080-20tests | Abbexa | 20 tests | 309.6 EUR |
Human Hepatitis B Virus Surface Antibody Rapid Test Kit |
|||
abx092013-25tests | Abbexa | 25 tests | 510 EUR |
Peste des Petits Ruminants Virus Antibody Rapid Test Kit |
|||
abx092068-50tests | Abbexa | 50 tests | 427.2 EUR |
TruStrip RDT Rat IgG Rapid Test cards, 10/pk |
|||
6420-RDT-10 | Alpha Diagnostics | 1 Pk | 205.2 EUR |
TruStrip RDT Rat IgG Rapid Test cards, 25/pk |
|||
6420-RDT-25 | Alpha Diagnostics | 1 Pk | 351.6 EUR |
TruStrip RDT Pig IgG Rapid Test cards, 10/pk |
|||
9020-RDT-10 | Alpha Diagnostics | 1 Pk | 205.2 EUR |
TruStrip RDT Pig IgG Rapid Test cards, 25/pk |
|||
9020-RDT-25 | Alpha Diagnostics | 1 Pk | 351.6 EUR |
Human Mycoplasma Pneumoniae (MP) IgG Rapid Test Kit |
|||
abx092081-20tests | Abbexa | 20 tests | 309.6 EUR |
Human Mycoplasma Pneumoniae (MP) IgM Rapid Test Kit |
|||
abx092082-20tests | Abbexa | 20 tests | 309.6 EUR |
TruStrip RDT Goat IgG Rapid Test cards, 10/pk |
|||
7520-RDT-10 | Alpha Diagnostics | 1 Pk | 205.2 EUR |
TruStrip RDT Goat IgG Rapid Test cards, 25/pk |
|||
7520-RDT-25 | Alpha Diagnostics | 1 Pk | 351.6 EUR |
Cardiac Troponin I (cTnI) rapid test (Colloidal Gold) |
|||
abx095265-80Units | Abbexa | 80 Units | 1579.2 EUR |
Anticyclic citrullinated peptide antibody rapid test (Colloidal Gold) |
|||
abx095260-80Units | Abbexa | 80 Units | 1579.2 EUR |
TruStrip RDT Human IgG Rapid test cards, 10/pk |
|||
20007-1-RDT | Alpha Diagnostics | 1 Pk | 205.2 EUR |
TruStrip RDT Human IgG Rapid test cards, 25/pk |
|||
20007-1-RDT-25 | Alpha Diagnostics | 1 Pk | 351.6 EUR |
To control the risk of releasing of infectious individuals under certain levels, rapid antigen tests should be designed to have lower detection limits than infectiousness threshold values to minimize the length of prolonged isolation, and the length of prolonged isolation increases when the detection limit is higher than the infectiousness threshold values, even though the guidelines are optimized for given conditions.